Swiss National Bank
DYN icon

Swiss National Bank’s Dyne Therapeutics DYN Stock Holding History

Swiss National Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.15M Buy
232,000
+3,900
+2% +$72.5K ﹤0.01% 1433
2026
Q1 		$4.14M Buy
228,100
+5,600
+3% +$96.6K ﹤0.01% 1468
2025
Q4 		$4.35M Buy
222,500
+44,200
+25% +$837K ﹤0.01% 1431
2025
Q3 		$2.26M Buy
178,300
+37,900
+27% +$432K ﹤0.01% 1802
2025
Q2 		$1.34M Buy
140,400
+22,100
+19% +$243K ﹤0.01% 2001
2025
Q1 		$1.24M Buy
118,300
+9,700
+9% +$139K ﹤0.01% 2037
2024
Q4 		$2.56M Buy
108,600
+3,500
+3% +$104K ﹤0.01% 1717
2024
Q3 		$3.78M Sell
105,100
-800
-0.8% -$31.8K ﹤0.01% 1493
2024
Q2 		$3.74M Buy
105,900
+20,700
+24% +$602K ﹤0.01% 1446
2024
Q1 		$2.42M Buy
85,200
+25,000
+42% +$565K ﹤0.01% 1735
2023
Q4 		$801K Sell
60,200
-3,300
-5% -$32.2K ﹤0.01% 2353
2023
Q3 		$569K Hold
63,500
– – ﹤0.01% 2477
2023
Q2 		$714K Buy
63,500
+7,200
+13% +$84.9K ﹤0.01% 2458
2023
Q1 		$649K Sell
56,300
-6,200
-10% -$80.5K ﹤0.01% 2461
2022
Q4 		$724K Buy
62,500
+1,700
+3% +$19.7K ﹤0.01% 2482
2022
Q3 		$772K Hold
60,800
– – ﹤0.01% 2438
2022
Q2 		$418K Buy
60,800
+5,900
+11% +$40.6K ﹤0.01% 2654
2022
Q1 		$529K Buy
54,900
+3,900
+8% +$33.2K ﹤0.01% 2592
2021
Q4 		$606K Hold
51,000
– – ﹤0.01% 2629
2021
Q3 		$828K Hold
51,000
– – ﹤0.01% 2484
2021
Q2 		$1.07M Buy
+51,000
New +$959K ﹤0.01% 2446

Other funds holding DYN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Swiss National Bank's DYN Position: Q2 2026 in Review

Swiss National Bank increased its Dyne Therapeutics (DYN) stake by 1.7% in Q2 2026, buying an estimated $72.5K and bringing the position to 232,000 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Swiss National Bank first reported a position in DYN in Q2 2021 and has held it in 21 quarters since. 84 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Swiss National Bank held 232,000 shares of Dyne Therapeutics worth $5.15M as of Q2 2026.
  • Swiss National Bank bought 3,900 Dyne Therapeutics shares in Q2 2026, an estimated $72.5K.
  • Dyne Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1433 holding.
  • Swiss National Bank first reported a position in Dyne Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 84 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.